By Marcus Devlin
Two decades covering equity markets. Writes on single stocks, sectors, valuations and the trades behind the tape.
Ralph Lauren beats estimates on Asia boom, but forecast disappoints
Ralph Lauren topped quarterly expectations thanks to a 24% surge in Asia sales, but its annual forecast disappointed. The company raised its
Tarsus to buy Alkeus for up to $800M, adding Stargardt disease drug
Tarsus Pharmaceuticals is buying Alkeus for up to $800 million, adding a late-stage treatment for Stargardt disease, a rare inherited retina
Unitree prices Shanghai IPO at 150.8 yuan, valuing humanoid robot maker at 61 billion yuan
Unitree, the Hangzhou-based humanoid robot maker, has priced its Shanghai STAR Market IPO at 150.8 yuan per share, valuing the company at ro
Datadog beats Q2 and raises outlook, but shares slide on soft Q3 forecast
Datadog beat Wall Street's Q2 expectations and raised its full-year revenue outlook, but its forecast for slower third-quarter growth knocke
UK clears Paramount's $110B Warner Bros. Discovery deal
UK regulators have cleared Paramount's $110 billion acquisition of Warner Bros. Discovery after David Ellison made legally binding promises
LIC's quarterly profit jumps 23% on group sales, better margins
India's state-backed insurer LIC reported a 23% jump in quarterly profit, driven by strong group policy sales and a shift toward higher-marg
Fox beats estimates as World Cup ads lift revenue 78%
Fox beat estimates as World Cup advertising drove a 78% jump in ad revenue to $1.92 billion. The company also signaled a bigger streaming pu
Stock Futures Mixed as Iran-Oman Hormuz Shipping Plan Nears
US stock futures were mixed early Thursday as oil prices ticked up and traders watched for signs Iran and Oman are close to a shipping safet
Molson Coors tops Q2 forecasts as price hikes offset falling beer volumes
Molson Coors beat Wall Street's second-quarter expectations even as beer volumes fell, thanks to higher prices and a shift toward premium br
BMO raises Novo Nordisk target to $47 but seeks clearer growth plan
BMO Capital Markets raised its price target on Novo Nordisk to $47 and boosted 2026 earnings estimates after the drugmaker's Q2 results. How
Ferrari lifts 2026 revenue target after strong second quarter
Ferrari reported an 8% rise in quarterly net revenue to €1.94 billion and nudged up its 2026 revenue target. Analysts at AlphaValue/Baader E
EPAM trims 2026 revenue outlook as tech clients pull back
EPAM Systems trimmed its 2026 revenue growth forecast to 3.2%-4.2% as demand split by client type. Financial services held up with 11.5% gro